To further explore the impact of IRF1 on AML progression in vivo, we intravenously injected NSG mice with luciferase-labeled MV4-11 or Kasumi-1 cells from sh-IRF1#1 and sh-NC groups (Fig. 4A). Here, IRF1 is linked to acute myeloid leukemia.